Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue — Trials · CancerIndex

Clinical trials

Registered studies

169 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00210327	VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy	completed	Phase 2	33	International Extranodal Lymphoma Study Group (IELSG)OTHER	1	Jul 22, 2009	clinicaltrials
NCT00373646	Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients	completed	Phase 2	8	Medical University of ViennaOTHER	1	Jun 18, 2009	clinicaltrials